PureTech Health plc
NASDAQ:PRTCBiotechnology
Healthcare
$17.38 +2.64%
+$0.45 today
- Market cap
- $423.09M
- Beta
- 0.79
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$45.37
52W Low $14.50High $19.92
Volume 0.01M
Average 0.01M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$85.33M
FY 2025 · Annual
Investing Cash Flow
$63.44M
FY 2025 · Annual
-73.7% YoYFinancing Cash Flow
-$6.34M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (62.71M) | (37.07M) | (65.7M) | 27.78M | (110M) |
| Depreciation & Amortization | 7.29M | 8.89M | 4.93M | 3.57M | 3.36M |
| Deferred Income Tax | (112.61M) | (70.12M) | 0 | 0 | 0 |
| Stock-Based Compensation | 13.95M | 14.7M | 4.42M | 22.85M | 8.22M |
| Change in Working Capital | 861K | 15.92M | 17.52M | (10.24M) | (3.13M) |
| Accounts Receivables | (617K) | (7.73M) | 9.75M | 629K | (236.55K) |
| Inventory | (103K) | 0 | 0 | 0 | 0 |
| Accounts Payables | 8.34M | 22.03M | 3.84M | (9.7M) | (1.03M) |
| Other Working Capital | (6.76M) | 1.62M | 3.93M | (1.17M) | (1.87M) |
| Other Non-Cash Items | (5.05M) | (111.12M) | (67.09M) | (178.34M) | 16.22M |
| Operating Cash Flow | (158.27M) | (178.79M) | (105.92M) | (134.37M) | (85.33M) |
| Capital Expenditures | (5.66M) | (2.18M) | (245K) | (11K) | (6.01K) |
| Acquisitions (Net) | 321K | (20.44M) | (13.78M) | (105.97M) | 269.63K |
| Purchases of Investments | (500K) | (268.73M) | (195.71M) | (309.6M) | (85.29M) |
| Sales of Investments | 218.13M | 183.71M | 277.87M | 656.22M | 148.41M |
| Other Investing Activities | (14.91M) | 416K | 865K | 255K | 49.11K |
| Investing Cash Flow | 197.38M | (107.22M) | 68.99M | 240.89M | 63.44M |
| Debt Repayment | 2.22M | 393K | (3.34M) | (3.39M) | 0 |
| Common Stock Issued | 38.03M | 332K | 1.15M | 895K | 106.25K |
| Common Stock Repurchased | (13.33M) | (26.49M) | (19.65M) | (107.56M) | (2.06M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 33.84M | (4.07M) | 99.98M | 93.1M | (4.39M) |
| Financing Cash Flow | 22.73M | (29.83M) | 78.14M | (16.96M) | (6.34M) |
| Effect of Forex Changes | (1K) | 0 | 0 | 0 | 19.83K |
| Net Change in Cash | 61.83M | (315.84M) | 41.22M | 89.56M | (28.22M) |
| Free Cash Flow | (163.94M) | (180.97M) | (106.16M) | (134.38M) | (85.34M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$110.0M
+ D&A$3.4M
+ Stock-Based Comp$8.2M
+ Deferred Tax$0
- Working Capital-$3.1M
+ Other Non-Cash$16.2M
= Operating Cash Flow-$85.3M
- Capex-$6.0K
= Free Cash Flow-$85.3M
Analysis
FY2025 free cash flow is -$85.3M. FCF conversion is 77.6% of net income. Operating cash flow was -$85.3M, with capex of -$6.0K. The largest bridge item is Other Non-Cash at $16.2M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| F-6 POS | F-6 POS filing | May 22, 2026 | |
| 15F-12B | 15F-12B filing | May 21, 2026 | |
| 424B3 | 424B3 filing | May 21, 2026 | |
| 25 | 25 filing | May 11, 2026 | |
| SC 13G/A | SC 13G/A filing | May 11, 2026 |
Does PRTC generate free cash flow?
PureTech Health plc (PRTC) generated -$85.34M of free cash flow in fiscal 2025.
How much operating cash flow does PRTC produce?
Operating cash flow was -$85.33M, before capital expenditures of $6,010.00.
Continue the stock analysis
Jump to another research area for this company.